top of page
Website Images_COEDs Feb. 2024 (1).png

Total Health's 2024 Community Oncology Educational Discussion Series (COEDS) consists of educational activities designed to meet the educational needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of breast cancer. The agenda is comprised of multidisciplinary, case-based presentations that break down the most clinically relevant information applicable to community care. This accredited meeting is hosted as an in-person conference only.

Program Chair

Website Agenda.png
Website Agenda.png

Venue Information

Farmer's Table

1901 N Military Trl

Boca Raton, FL 33431

2020-10-17.jpg

Accreditation Information | 1.25

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Nurses (ANCC) Credit Designation

Amedco LLC designates this activity for a maximum of 1.25 ANCC contact hours.

 

Physicians (ACCME) Credit Designation

Amedco LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

Amedco LLC designates this activity for a maximum of 1.25 knowledge-based CPE contact hours.


NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor. 

Learning Objectives

  • Employ an understanding of personalized medicine to individualize the use of available drugs for breast cancers.

  • Communicate the efficacy and safety of the drugs discussed in the case studies and other emerging treatments for breast cancers.

  • Understand the emerging and standard diagnostic tests used to assist in planning therapy for breast cancers.

  • Formulate management strategies, considering the contributory roles of local and systemic therapy.

  • Recall the design of ongoing clinical trials evaluating novel investigational agents and counsel appropriately selected patients about availability and participation.

IMG_5254.jpg

What to Expect
In-Person Learners

  • Free registration for all healthcare providers   

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies  

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals 

  • Access to the latest industry information and resources  

  • Catered meals through-out the program

Become an Exhibitor 

Follow for Updates

bottom of page